3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
1
Neoplasms
1
Nausea
1
Breast Neoplasms
1
Interventions
Dexamethasone
38
Aprepitant
31
Ondansetron
27
Palonosetron
25
Granisetron
16
Calcium Dobesilate
15
Olanzapine
12
Therapeutics
8
dexamethasone acetate
7
Cyclophosphamide
7
fosaprepitant
6
casopitant
6
Doxorubicin
6
Radiotherapy
5
netupitant
4
dolasetron
4
dexamethasone 21-phosphate
4
Vincristine
4
Tropisetron
4
Metoclopramide
4
Acupressure
4
Yoga
3
Psychiatric Rehabilitation
3
Prochlorperazine
3
Lorazepam
3
Electroacupuncture
3
Dronabinol
3
Cisplatin
3
Analgesia
3
peppermint oil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Nausea
×
alizapride
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts